Foghorn Therapeutics FHTX
NASDAQ FHTX
$3.57 +0.05 (+1.42%)
At close: Sep 30, 2026 · 4:00 PM EDT

Foghorn Therapeutics (FHTX) Other Operating Expenses (2024 - 2025)

Updated

Foghorn Therapeutics (FHTX) reported Other Operating Expenses of $4.28 million for Q4 2025.

Analysis

Foghorn Therapeutics (FHTX) Other Operating Expenses (2024 - 2025) Analysis & Trends

  • By year, Other Operating Expenses came in at $2.4 million in FY2024.
  • The Q4 2025 figure ranks as the lowest quarterly Other Operating Expenses since Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Foghorn Therapeutics 209.61 Mn -116.34 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 4.28 Mn
Jun 30, 2024 2.40 Mn
API Access

Foghorn Therapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=FHTX&period=max&api_key=YOUR_API_KEY